Recent Growth Trends In The Cell And Gene Therapy Market
Cell and gene therapy (CGT) has made major advances in patient care by helping to treat or potentially cure a range of diseases untouched by small molecules and biologics. Over the past two decades, the US FDA has approved more than 20 CGTs, many of which cost between $375,00 and $2 million for one-time treatments. […]
Recent Growth Trends In The Cell And Gene Therapy Market Read More »